First Time Loading...
X

Xilio Therapeutics Inc
NASDAQ:XLO

Watchlist Manager
Xilio Therapeutics Inc
NASDAQ:XLO
Watchlist
Price: 1.18 USD 12.38% Market Closed
Updated: May 5, 2024

Xilio Therapeutics Inc
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xilio Therapeutics Inc
Cash from Investing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
X
Xilio Therapeutics Inc
NASDAQ:XLO
Cash from Investing Activities
-$486k
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Investing Activities
-$2B
CAGR 3-Years
62%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Cash from Investing Activities
-$2.3B
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
-76%
Amgen Inc
NASDAQ:AMGN
Cash from Investing Activities
-$26.2B
CAGR 3-Years
-69%
CAGR 5-Years
N/A
CAGR 10-Years
-12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Investing Activities
-$3.1B
CAGR 3-Years
N/A
CAGR 5-Years
-73%
CAGR 10-Years
-50%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Investing Activities
-$3.2B
CAGR 3-Years
-256%
CAGR 5-Years
-17%
CAGR 10-Years
-25%

See Also

What is Xilio Therapeutics Inc's Cash from Investing Activities?
Cash from Investing Activities
-486k USD

Based on the financial report for Dec 31, 2023, Xilio Therapeutics Inc's Cash from Investing Activities amounts to -486k USD.

What is Xilio Therapeutics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
39%

Over the last year, the Cash from Investing Activities growth was 74%. The average annual Cash from Investing Activities growth rates for Xilio Therapeutics Inc have been 39% over the past three years .